Literature DB >> 17920917

Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study.

José Boggia1, Yan Li, Lutgarde Thijs, Tine W Hansen, Masahiro Kikuya, Kristina Björklund-Bodegård, Tom Richart, Takayoshi Ohkubo, Tatiana Kuznetsova, Christian Torp-Pedersen, Lars Lind, Hans Ibsen, Yutaka Imai, Jiguang Wang, Edgardo Sandoya, Eoin O'Brien, Jan A Staessen.   

Abstract

BACKGROUND: Few studies have formally compared the predictive value of the blood pressure at night over and beyond the daytime value. We investigated the prognostic significance of the ambulatory blood pressure during night and day and of the night-to-day blood pressure ratio.
METHODS: We did 24-h blood pressure monitoring in 7458 people (mean age 56.8 years [SD 13.9]) enrolled in prospective population studies in Denmark, Belgium, Japan, Sweden, Uruguay, and China. We calculated multivariate-adjusted hazard ratios for daytime and night-time blood pressure and the systolic night-to-day ratio, while adjusting for cohort and cardiovascular risk factors.
FINDINGS: Median follow-up was 9.6 years (5th to 95th percentile 2.5-13.7). Adjusted for daytime blood pressure, night-time blood pressure predicted total (n=983; p<0.0001), cardiovascular (n=387; p<0.01), and non-cardiovascular (n=560; p<0.001) mortality. Conversely, adjusted for night-time blood pressure, daytime blood pressure predicted only non-cardiovascular mortality (p<0.05), with lower blood pressure levels being associated with increased risk. Both daytime and night-time blood pressure consistently predicted all cardiovascular events (n=943; p<0.05) and stroke (n=420; p<0.01). Adjusted for night-time blood pressure, daytime blood pressure lost prognostic significance only for cardiac events (n=525; p> or =0.07). Adjusted for the 24-h blood pressure, night-to-day ratio predicted mortality, but not fatal combined with non-fatal events. Antihypertensive drug treatment removed the significant association between cardiovascular events and the daytime blood pressure. Participants with systolic night-to-day ratio value of 1 or more were older, at higher risk of death, and died at an older age than those whose night-to-day ratio was normal (> or =0.80 to <0.90).
INTERPRETATION: In contrast to commonly held views, daytime blood pressure adjusted for night-time blood pressure predicts fatal combined with non-fatal cardiovascular events, except in treated patients, in whom antihypertensive drugs might reduce blood pressure during the day, but not at night. The increased mortality in patients with higher night-time than daytime blood pressure probably indicates reverse causality. Our findings support recording the ambulatory blood pressure during the whole day.

Entities:  

Mesh:

Year:  2007        PMID: 17920917     DOI: 10.1016/S0140-6736(07)61538-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  220 in total

1.  Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD.

Authors:  Ramón C Hermida; Diana E Ayala; Artemio Mojón; José R Fernández
Journal:  J Am Soc Nephrol       Date:  2011-10-24       Impact factor: 10.121

2.  Automatic identification of activity-rest periods based on actigraphy.

Authors:  Cristina Crespo; Mateo Aboy; José Ramón Fernández; Artemio Mojón
Journal:  Med Biol Eng Comput       Date:  2012-03-01       Impact factor: 2.602

3.  Altered sleep-related blood pressure profile in hypocretin-deficient narcoleptic patients.

Authors:  Yves Dauvilliers
Journal:  Sleep       Date:  2012-04-01       Impact factor: 5.849

4.  Sleep related changes in blood pressure in hypocretin-deficient narcoleptic mice.

Authors:  Stefano Bastianini; Alessandro Silvani; Chiara Berteotti; Jean-Luc Elghozi; Carlo Franzini; Pierluigi Lenzi; Viviana Lo Martire; Giovanna Zoccoli
Journal:  Sleep       Date:  2011-02-01       Impact factor: 5.849

5.  Effect of CPAP therapy on nocturnal blood pressure fluctuations, nocturnal blood pressure, and arterial stiffness in patients with coexisting cardiovascular diseases and obstructive sleep apnea.

Authors:  Frauke Picard; Petroula Panagiotidou; Laura Weinig; Maximilian Steffen; Anne-Beke Tammen; Rolf Michael Klein
Journal:  Sleep Breath       Date:  2020-04-15       Impact factor: 2.816

6.  Night-time systolic blood pressure and subclinical cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study.

Authors:  Koki Nakanishi; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Joseph E Schwartz; Tetz C Lee; Aylin Tugcu; Mitsuhiro Yoshita; Charles DeCarli; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-07-01       Impact factor: 6.875

Review 7.  Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome.

Authors:  Badhma Valaiyapathi; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

8.  A daytime normotensive patient with nocturnal hypoxia-induced hypertension and severe obstructive sleep apnea.

Authors:  Hiromitsu Sekizuka; Satoshi Hoshide; Naohiko Osada; Yoshihiro J Akashi; Kazuomi Kario
Journal:  J Cardiol Cases       Date:  2017-06-30

Review 9.  Effect of childhood obesity prevention programs on blood pressure: a systematic review and meta-analysis.

Authors:  Li Cai; Yang Wu; Renee F Wilson; Jodi B Segal; Miyong T Kim; Youfa Wang
Journal:  Circulation       Date:  2014-02-19       Impact factor: 29.690

Review 10.  Ambulatory blood pressure monitoring in the prediction and prevention of coronary heart disease.

Authors:  Yuan-Yuan Kang; Yan Li; Ji-Guang Wang
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.